This brief reports what ServiceNow's 10-Q, filed 2026-04-23, states, and nothing else. Every item below is a sentence the filing contains, quoted exactly and verified character-for-character against the document fetched from EDGAR. No inference is drawn and no claim is made about what any figure means.
The figures
| Metric | Value | Period |
|---|---|---|
| RPO | $27.7 billion | March 31, 2026 |
| RPO | 25% | March 31, 2026 |
| CRPO | 23% | March 31, 2026 |
| Number of customers with ACV greater than $5 million | 630 | March 31, 2026 |
| Number of customers with ACV greater than $5 million | 516 | March 31, 2025 |
| Total operating lease costs | $42 million | three months ended March 31, 2026 |
| Total operating lease costs | $36 million | three months ended March 31, 2025 |
| Total cash paid for amounts included in the measurement of operating lease liabilities | $29 million | three months ended March 31, 2026 |
| Total cash paid for amounts included in the measurement of operating lease liabilities | $24 million | three months ended March 31, 2025 |
| Operating lease liabilities arising from obtaining operating right-of-use assets | $61 million | three months ended March 31, 2026 |
| Operating lease liabilities arising from obtaining operating right-of-use assets | $141 million | three months ended March 31, 2025 |
| Weighted-average remaining lease term | approximately eight years | March 31, 2026 |
| Weighted-average discount rate | 4% | March 31, 2026 |
| Remaining payments under agreement with information technology equipment provider | $1.4 billion | by fiscal 2028 |
| Unrecognized tax benefits | $148 million | March 31, 2026 |
| Renewal rate | 98% | over the last three years |
| Cash and cash equivalents, marketable securities and long-term marketable securities | $7.9 billion | March 31, 2026 |
| Operating lease obligations | $1.1 billion | — |
| Operating lease obligations | $716 million | over the next five years |
| Outstanding payment obligations to suppliers participating in the SCF program | $29 million | March 31, 2026 |
| Share Repurchase Program | $3.0 billion | In January 2025 |
| Share Repurchase Program | $5.0 billion | In January 2026 |
| Share Repurchase Program | $2.0 billion | On January 30, 2026 |
| ASR transaction | 18.5 million shares | during the three months ended March 31, 2026 |
| ASR transaction | $107.97 per share | during the three months ended March 31, 2026 |
| Open market transactions | 1.6 million shares | during the three months ended March 31, 2026 |
| Open market transactions | $225 million | during the three months ended March 31, 2026 |
| Authorized amount under the Share Repurchase Program | $4.2 billion | March 31, 2026 |
| Net cash provided by operating activities | $1,670 | Three Months Ended March 31, 2026 |
| Net cash provided by operating activities | $1,677 | Three Months Ended March 31, 2025 |
| Professional services and other gross loss percentage | 21% | three months ended March 31, 2026 |
| Sales and marketing expenses | $162 million | three months ended March 31, 2026 |
| Stock-based compensation | $88 million | three months ended March 31, 2026 |
| Revenues outside North America | 37% | three months ended March 31, 2026 |
| Sales and marketing expenses | $162 million | the three months ended March 31, 2026 |
| Research and development expenses (R&D) | $120 million | the three months ended March 31, 2026 |
| General and administrative expenses (G&A) | $59 million | the three months ended March 31, 2026 |
| Stock-based compensation | $88 million | the three months ended March 31, 2026 |
Every figure above is quoted from the filing; the sentence it was read from appears under its beat below.
The evidence, by beat
ARR / NRR / NDR growth or dilution
As of March 31, 2026, our RPO was $27.7 billion, of which 46% represented cRPO.
RPO and cRPO increased by 25% and 23%, respectively, compared to March 31, 2025.
RPO and cRPO increased by 25% and 23%, respectively, compared to March 31, 2025.
We had 630 and 516 customers with ACV greater than $5 million as of March 31, 2026 and 2025, respectively.
We had 630 and 516 customers with ACV greater than $5 million as of March 31, 2026 and 2025, respectively.
seat vs consumption / usage-based pricing mix shift
Total operating lease costs were $42 million and $36 million for the three months ended March 31, 2026 and 2025, respectively.
Total operating lease costs were $42 million and $36 million for the three months ended March 31, 2026 and 2025, respectively.
For the three months ended March 31, 2026 and 2025, total cash paid for amounts included in the measurement of operating lease liabilities was $29 million and $24 million, respectively.
For the three months ended March 31, 2026 and 2025, total cash paid for amounts included in the measurement of operating lease liabilities was $29 million and $24 million, respectively.
Operating lease liabilities arising from obtaining operating right-of-use assets totaled $61 million and $141 million for the three months ended March 31, 2026 and 2025, respectively.
Operating lease liabilities arising from obtaining operating right-of-use assets totaled $61 million and $141 million for the three months ended March 31, 2026 and 2025, respectively.
As of March 31, 2026, the weighted-average remaining lease term is approximately eight years, and the weighted-average discount rate is 4%.
As of March 31, 2026, the weighted-average remaining lease term is approximately eight years, and the weighted-average discount rate is 4%.
In addition, we have entered into a non-cancellable agreement with an information technology equipment provider, under which we have remaining payments of approximately $1.4 billion due by fiscal 2028.
Further, $148 million of unrecognized tax benefits have been recorded as liabilities as of March 31, 2026.
competitive displacement / win-loss / platform consolidation
The enacted legislation had an immaterial impact on the Company’s effective tax rate for the three months ended March 31, 2026.
we have experienced a renewal rate of 98% over the last three years.
We have generated positive operating cash flows for more than ten years as we continue to grow our business in pursuit of our business strategy, and we expect to grow our business and generate positive cash flows from operations during 2026.
We have generated positive operating cash flows for more than ten years as we continue to grow our business in pursuit of our business strategy, and we expect to grow our business and generate positive cash flows from operations during 2026.
cash and cash equivalents, marketable securities and long-term marketable securities totaling $7.9 billion as of March 31, 2026.
Operating lease obligations totaling $1.1 billion are principally associated with leased facilities and have varying maturities with $716 million due over the next five years.
Operating lease obligations totaling $1.1 billion are principally associated with leased facilities and have varying maturities with $716 million due over the next five years.
As of March 31, 2026, our outstanding payment obligations to suppliers participating in the SCF program totaled $29 million.
In January 2025 and January 2026, our board of directors authorized an additional $3.0 billion and $5.0 billion, respectively, in repurchases under the Share Repurchase Program.
In January 2025 and January 2026, our board of directors authorized an additional $3.0 billion and $5.0 billion, respectively, in repurchases under the Share Repurchase Program.
On January 30, 2026, we entered into an ASR agreement with a financial institution to repurchase an aggregate of $2.0 billion of our common stock as part of the Share Repurchase Program.
During the three months ended March 31, 2026, the Company completed the ASR transaction with 18.5 million shares of common stock repurchased at an average price of $107.97 per share, which was determined based on the volume weighted average price over the term of the ASR, less an agreed upon discount.
During the three months ended March 31, 2026, the Company completed the ASR transaction with 18.5 million shares of common stock repurchased at an average price of $107.97 per share, which was determined based on the volume weighted average price over the term of the ASR, less an agreed upon discount.
During the three months ended March 31, 2026, the Company repurchased an additional 1.6 million shares of our common stock for $225 million in open market transactions.
During the three months ended March 31, 2026, the Company repurchased an additional 1.6 million shares of our common stock for $225 million in open market transactions.
As of March 31, 2026, approximately $4.2 billion of the authorized amount under the Share Repurchase Program remained available for future repurchases.
Three Months Ended March 31,20262025 (dollars in millions)Net cash provided by operating activities$1,670 $1,677
Three Months Ended March 31,20262025 (dollars in millions)Net cash provided by operating activities$1,670 $1,677
AI product monetisation / attach
The filing names this beat, but no statement in it verified as a verbatim quote, so none is reported here.
guidance raised/cut, outlook change
Our professional services and other gross loss percentage was 21% for the three months ended March 31, 2026 compared to 8% for the three months ended March 31, 2025
We expect our professional services and other gross loss percentage to increase for the year ending December 31, 2026 compared to the year ended December 31, 2025
Sales and marketing expenses increased by $162 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025
We expect R&D expenses for the year ending December 31, 2026 to increase in absolute dollars but remain relatively flat as a percentage of revenue compared to the year ended December 31, 2025
We expect G&A expenses for the year ending December 31, 2026 to increase in absolute dollars but remain relatively flat as a percentage of revenue compared to the year ended December 31, 2025
Stock-based compensation increased by $88 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025
we expect stock-based compensation to continue to increase in absolute dollars for the year ending December 31, 2026 as we continue to issue stock-based awards to our employees but remain relatively flat as a percentage of revenue compared to the year ended December 31, 2025
Revenues outside North America represented 37% and 36% for the three months ended March 31, 2026 and 2025, respectively
Scope: compared to 36% for the three months ended March 31, 2025.
cost action / restructuring / headcount
Sales and marketing expenses increased by $162 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily due to increased headcount resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $73 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025.
Research and development expenses (“R&D”) increased by $120 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily due to increased headcount, resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $116 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025.
General and administrative expenses (“G&A”) increased by $59 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily due to an increase in outside services of $35 million, largely related to acquisitions, and an increase in personnel-related costs.
Stock-based compensation increased by $88 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily due to additional grants to current and new employees and stock-based awards granted in connection with acquisitions.
Verification ledger
- 62 statements proposed by the extractor
- 45 verified verbatim against the fetched filing (73%)
- 17 discarded — not quotable character-for-character
The verbatim check contains no model: the extractor proposes a statement, and a deterministic substring match against the fetched text decides whether it is admissible. A proposal that does not verify is dropped.
This brief publishes no inference and no synthesis. The publication's inference layer must clear a measured second-lab confirmation threshold before it may appear; it has not, so it is absent by rule rather than by omission.